About Pyrogen Testing
Pyrogen is a substance that can cause fever majorly in the animal body which injected with some injectable drugs. These are derived from bacteria, fungi, and viruses. Hence according to the FDA, it is necessary that every drug should be Pyrogen free. Therefore there are some sets of regulations that can meet pyrogen limit specifications before they are marketed. Furthermore, all the information mentioned above pyrogen needs a testing device to be detected. Also, the rising trend of using Non-animal monocyte activation tests (MAT) is widely available but infrequently used for pyrogen testing is conducting the market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 13.2% |
The global market is highly competitive and consists of a limited number of providers competing. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Pyrogen Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Cape Cod, Inc. (United States), Charles River Laboratories International, Inc. (United States), Ellab A/S (Denmark), GenScript (United States), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (United States), Wako Chemicals USA Inc. (United States) and Wuxi PharmaTech (CAYMAN) Inc. (China) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Pyrogen Testing market by Type (Instruments, Services and Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices and Other) and Region.
On the basis of geography, the market of Pyrogen Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Pyrogen Test, the sub-segment i.e. Rabbit pyrogen test (RPT) will boost the Pyrogen Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Monocyte Activation Test is Expected to Witness Highest Growth Rate in Terms of Segmentation and Shift Tradition from Animal-Based Testing to in Vitro Testing
Market Growth Drivers:
Increased Demand for Pyrogenic Testing Products in the Pharmaceutical and Biotechnology Industry, Rising Number of New Drug Launches and Strong Government Support for Pharmaceutical and Biotechnology Industry
Challenges:
Rising Number of Outsourcing Activities in Pharmaceutical Industries
Restraints:
Stringent Government Regulations for these Drugs and High Degree of Consolidation
Opportunities:
High Investments in Research and Development in the Life Science Industry and Rising Number of Launches of Biologic Products
Market Leaders and their expansionary development strategies
In July 2020, Lonza Sales AG and Sanquin Reagents BV entered a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the monocyte activation test (MAT).
In October 2023, Lonza expanded its PyroCell pyrogen testing portfolio with the launch of two new rapid systems, the PyroCell MAT Rapid System and PyroCell MAT Human Serum (HS) Rapid System. These systems aim to streamline and simplify rabbit-free pyrogen testing.
Key Target Audience
Potential Investors, Government Bodies and Associations, Up and Down Stream Vendors, Private Research Organizations, Suppliers and Distributors and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.